Global Market for Preclinical In-vivo Imaging is estimated to be grow April.2017 | Page 2

Global Preclinical In-vivo Imaging Market According to the report " Preclinical In-vivo Imaging Market", published by Market Data Forecast, the global market is projected to reach USD 1004.05 Million by 2021, at a CAGR of 6.15% from 2016 to 2021. Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Development of technologically advanced hybrid preclinical imaging systems and growing acceptance of preclinical imaging as a legitimate drug development tool are the factors that are driving the market growth globally. Growing number of CROs in emerging markets is attracting companies to invest in those region. Global market for Preclinical in-vivo imaging is segmented based on Type and Product into further sub-segments as follows: 1. By Modality  Optical imaging  Bioluminescence/fluorescence imaging systems  Standalone fluorescence imaging systems  Optical + X-ray/optical + CT imaging systems  Nuclear imaging  Micro-PET systems (standalone PET, PET/CT, and PET/MRI)  Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)  Tri-modality (PET/SPECT/CT) imaging systems  Micro-MRI  Micro-CT  Micro-ultrasound  Photoacoustic  Magnetic particle imaging systems 2. By Reagents  Optical imaging reagents  Bioluminescent reagents  Fluorescent imaging reagents  Nuclear imaging reagents  Preclinical PET tracers  Preclinical SPECT probes  MRI contrast agents  Ultrasound contrast agents  CT contrast agents Geographically, the market for Preclinical in-vivo imaging market is segmented as below: [phone] | www.marketdataforecast.com | [email protected]